DISHMANPHARMA Dishman Pharma on Friday said it has posted consolidated net profit of Rs 26.59 crore for the quarter ended September 30, mainly on account of robust sales across all verticals.

The net profit figure takes into account taxes, minority interest and share of associates, the company said.

It had posted net loss of Rs 6.33 crore for the July— September quarter last year, Dishman Pharmaceuticals and Chemicals said in a statement.

Net sales of the company stood at Rs 289.26 crore as against Rs 268.84 crore.

The company operates in the area of contract research and manufacturing segment (CRAMS) as well as in bulk drugs, intermediates and speciality chemicals among others.

Dishman Pharma scrip settled at Rs 96.45 on the BSE, down 2.18 per cent from its previous close.

(This article was published on November 2, 2012)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.